Skip to main content

Clinical trials

Clinical research, regulatory and compliance information from BioAgile Therapeutics.

Need Expert Help? We’re Just a Call Away.
Hospital patient monitor and clock beside a safety report folder, illustrating serious adverse event reporting timelines

Serious adverse event reporting in Indian clinical trials: who reports, to whom and by when

By Sahithya K · Reviewed by Divya Chandradhara · Published 8 November 2026 Under the New Drugs and Clinical Trials Rules, 2019, the investigator must report every serious adverse event in a clinical trial to the Central Licencing Authority, the sponsor and the approving Ethics Committee within twenty-four hours of its occurrence. An analysed report […]
Continue Reading
Clinical research associate reviewing trial data on a tablet at a clinical site, illustrating ICH GCP E6(R3) principles

ICH GCP guidelines: the 11 principles of ICH E6(R3) and what changed for sponsors

By Sahithya K · Reviewed by Divya Chandradhara · Published 6 November 2026 ICH GCP is the International Council for Harmonisation’s guideline for good clinical practice, the ethical and scientific quality standard for designing, conducting, recording and reporting clinical trials. Its current version, ICH E6(R3), was adopted in two stages: the principles and Annex 1 […]
Continue Reading
Laptop showing an online registry dashboard at a clinical trial site, illustrating CTRI registration in India

CTRI registration: how a clinical trial is registered with the Clinical Trials Registry of India

By Sahithya K · Reviewed by Divya Chandradhara · Published 4 November 2026 CTRI registration is the entry of a clinical study in the Clinical Trials Registry – India, the free, searchable public registry for studies conducted in India. Registration must be completed before the first participant is enrolled. A trial that starts enrolment first […]
Continue Reading